Evidence map›Paper›PMID 26751374›Full record

ArticlePloS one2016

Gardnerella vaginalis Subgroups Defined by cpn60 Sequencing and Sialidase Activity in Isolates from Canada, Belgium and Kenya.

John J Schellenberg, Teenus Paramel Jayaprakash, Niradha Withana Gamage, Mo H Patterson, Mario Vaneechoutte, Janet E Hill

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Further dissection ofInternational journal of systematic and evolutionary microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Bacterial vaginosis: a sexually transmitted disease?Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
  9. mSystems · 2024
    Article
  10. Vaginal microbiota of pregnant women withFrontiers in cellular and infection microbiology · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Infection and immunity · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

John J SchellenbergDepartment of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada.
Teenus Paramel JayaprakashDepartment of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada.
Niradha Withana GamageDepartment of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada.
Mo H PattersonDepartment of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada.
Mario VaneechoutteLaboratory for Bacteriology Research, Ghent University, Ghent, Belgium.
Janet E HillDepartment of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Canada.
University of Saskatchewan · CAGhent University · BE

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Increased abundance of Gardnerella vaginalis and sialidase activity in vaginal fluid is associated with bacterial vaginosis (BV), a common but poorly understood clinical entity associated with poor reproductive health outcomes. Since most women are colonized with G. vaginalis, its status as a normal member of the vaginal microbiota or pathogen causing BV remains controversial, and numerous classification schemes have been described. Since 2005, sequencing of the chaperonin-60 universal target (cpn60 UT) has distinguished four subgroups in isolate collections, clone libraries and deep sequencing datasets. To clarify potential clinical and diagnostic significance of cpn60 subgroups, we undertook phenotypic and molecular characterization of 112 G. vaginalis isolates from three continents. A total of 36 subgroup A, 33 B, 35 C and 8 D isolates were identified through phylogenetic analysis of cpn60 sequences as corresponding to four "clades" identified in a recently published study, based on sequencing 473 genes across 17 isolates. cpn60 subgroups were compared with other previously described molecular methods for classification of Gardnerella subgroups, including amplified ribosomal DNA restriction analysis (ARDRA) and real-time PCR assays designed to quantify subgroups in vaginal samples. Although two ARDRA patterns were observed in isolates, each was observed in three cpn60 subgroups (A/B/D and B/C/D). Real-time PCR assays corroborated cpn60 subgroups overall, but 13 isolates from subgroups A, B and D were negative in all assays. A putative sialidase gene was detected in all subgroup B, C and D isolates, but only in a single subgroup A isolate. In contrast, sialidase activity was observed in all subgroup B isolates, 3 (9%) subgroup C isolates and no subgroup A or D isolates. These observations suggest distinct roles for G. vaginalis subgroups in BV pathogenesis. We conclude that cpn60 UT sequencing is a robust approach for defining G. vaginalis subgroups within the vaginal microbiome.

Indexed as

BelgiumBody FluidsCanadaChaperonin 60DNA PrimersDNA, RibosomalFemaleGardnerella vaginalisGenotypeHigh-Throughput Nucleotide SequencingHumansKenyaMicrobiotaNeuraminidasePhenotypePhylogenyChaperonin 60DNA PrimersDNA, RibosomalNeuraminidaseRNA, Ribosomal, 16S

Identifiers

PMID26751374
PMCPMC4709144
OpenAlexW2237593570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.